Diabetes

A recent trial assessed the cardiovascular effects of liraglutide, a glucagon-like peptide 1 analogue, when used in addition to standard treatment in patients with type 2 diabetes.

The neuroprotective potential of long-term metformin treatment was evaluated in a recent study.

New research investigated the prevalence of intensive treatment among patients with type 2 diabetes who do not use insulin and how it affected the risk of severe hypoglycemia.

A recent analysis compared the effect of canagliflozin and glimepiride on HbA1c reduction in patients with type 2 diabetes on background metformin.

New research finds that increased exposure to air pollution may heighten the risk of heart disease, especially among individuals with diabetes.

A 59-year-old man with diabetes presented with a 4-day history of an increasingly painful, swollen left foot.

Endorsed by 45 professional medical and surgical societies, new international guidelines out of the 2nd Diabetes Surgery Summit recommend metabolic surgery for the treatment of obese adults with type 2...

Aspirin has been used clinically since 1899, and its role for the secondary prevention of cardiovascular (CV) disease is well established.

Results of a recent study suggest that the combination of two common diabetes drugs could reduce mortality and the risk of adverse cardiovascular events.

A recent study aimed to quantify the risk of hypoglycemia in patients taking both DPP-4 inhibitors and sulphonylureas.